Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Motor Activity 12Breast Neoplasms 9Neoplasms 6Leukemia, Myeloid, Acute 3Prostatic Neoplasms 2Patient Compliance 2Neoplasm Metastasis 2Fatigue 2Depression 2Colorectal Neoplasms 2Brain Neoplasms 2Weight Loss 1Weight Gain 1Smoking Cessation 1Peripheral Nervous System Diseases 1Overweight 1Ovarian Neoplasms 1Obesity 1Neuroectodermal Tumors, Primitive 1Medulloblastoma 1Lung Neoplasms 1Insulin Resistance 1Infratentorial Neoplasms 1Fallopian Tube Neoplasms 1Disease 1Cognitive Dysfunction 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Bone Metabolism Biomarkers 1Body Weight Changes 1

Interventions

Metformin 4Inositol 2salicylsalicylic acid 1maltodextrin 1licogliflozin 1Tooth Exfoliation 1Sodium Salicylate 1Root Planing 1Pioglitazone 1Inulin 1Exercise 1Exenatide 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Insulin Resistance × Exercise × Clear all
NCT01340300 2018-06-06

Exercise and Metformin in Colorectal and Breast Cancer Survivors

Dana-Farber Cancer Institute

Phase 2 Completed
139 enrolled 18 charts
BreastGastrointestinal

Breast Neoplasms, Insulin Resistance, Motor Activity, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡